CCR5 and pulmonary fibrosis: To further analyze the influence of the CCR5 d32 deletion on the clinical course of the disease, the occurrence of the following symptoms of extra-articular disease was investigated: presence of nodular RA, major organ vasculitis, serositis, pulmonary fibrosis, or Raynaud's syndrome.